Tesamorelin is a synthetic GHRH analog supplied as a 10 mg
lyophilized vial for endocrine and growth hormone research.
Commonly studied for GH stimulation, IGF-1 pathway activation,
and metabolic regulation models.
For Research Use Only.
Synthetic growth hormone-releasing hormone (GHRH) analog supplied in lyophilized form
for advanced endocrine and metabolic research applications.
Tesamorelin is a stabilized analog of growth hormone-releasing hormone (GHRH),
designed to stimulate endogenous growth hormone production through pituitary activation.
In laboratory research settings, Tesamorelin is studied for its influence on growth hormone signaling,
IGF-1 production, and metabolic regulation pathways.
Investigated for its ability to stimulate pulsatile GH release via GHRH receptor activation.
Studied in endocrine research analyzing downstream IGF-1 production and anabolic signaling cascades.
Explored in laboratory environments evaluating lipid metabolism and visceral fat signaling pathways.
Used in controlled models examining hormonal feedback mechanisms and pituitary function.
| Compound | Tesamorelin |
|---|---|
| Amount | 10 mg per vial |
| Form | Lyophilized powder |
FOR RESEARCH USE ONLY. This product is not intended for human consumption,
medical use, diagnosis, treatment, or prevention of any disease.
Sold strictly for laboratory and scientific research purposes.
By purchasing, the buyer agrees to use this product in compliance with all applicable laws and regulations.